Published in Cardiovascular Week, October 24th, 2005
Researchers in the United States report, "Proteomic profiling of accessible bodily fluids, such as plasma, has the potential to accelerate biomarker/biosignature development for human diseases. The HUPO Plasma Proteome Project pilot phase examined human plasma with distinct proteomic approaches across multiple laboratories worldwide."
B.T. Berhane and colleagues of the University of California at Los Angeles wrote, "Through this effort, we confidently identified 3,020 proteins, each requiring a minimum of two high-scoring MS/MS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.